Related Experiment Video
Updated: Aug 9, 2026
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Identification of a mammalian melanosomal matrix glycoprotein
S J Orlow1, B K Zhou, R E Boissy
1Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NY 10016.
Abstract:
Antiserum raised in rabbits against the Triton X-100 insoluble fraction of melanosomes from mouse melanoma cells specifically decorates the internal matrix of melanosomes in immunoelectron microscopy. In metabolic labeling studies, the antiserum recognizes a protein of 94 kDa, which is processed to a band of 53 kDa. Whereas the precursor is relatively soluble in buffers containing Triton X-100, the processed protein requires the addition of sodium dodecyl sulfate for effective solubilization, as would be expected for a melanosomal matrix constituent. Tunicamycin reduces the Mr of the nascent protein to 75 kDa, but deoxymannojirimycin and swainsonine have no effect, suggesting that following initial glycosylation in the endoplasmic reticulum, the protein is not subject to processing by glycosidases in the Golgi apparatus or may bypass it entirely. Subcellular fractionation followed by immunoblotting confirms that the protein is present in the melanosome-rich, large granule fraction. Expression of the protein is regulated differently from that of the tyrosinase-related protein family. Conditions that greatly stimulate expression of tyrosinase-related proteins do not affect matrix protein expression, nor is the protein immunologically related to the tyrosinase-related protein family. Our results suggest that we have identified an authentic component of the mammalian melanosomal matrix, and that its characteristics lend support to a bipartite pathway for melanosomal biogenesis.
Insights
Researchers identified a novel protein component of the mammalian melanosome matrix. This discovery supports a bipartite pathway for melanosome biogenesis, distinct from other melanosomal proteins.
Area of Science:
- Cell Biology
- Biochemistry
- Melanogenesis Research
Background:
- Melanosomes are critical organelles for pigment production in mammals.
- The composition and biogenesis of the melanosomal matrix remain incompletely understood.
- Previous studies focused on enzymes like tyrosinase, leaving matrix components less characterized.
Purpose of the Study:
- To identify and characterize novel protein components of the mammalian melanosomal matrix.
- To investigate the biogenesis and processing of a newly identified melanosomal matrix protein.
- To determine the relationship of this protein to known melanosomal proteins and pathways.
Main Methods:
- Generation of specific antiserum against Triton X-100 insoluble melanosome fractions.
- Immunoelectron microscopy to localize the protein within melanosomes.
- Metabolic labeling and tunicamycin treatment to study protein processing and glycosylation.
- Subcellular fractionation and immunoblotting to confirm protein localization.
- Comparative expression analysis with tyrosinase-related proteins.
Main Results:
- A specific antiserum identified a 94 kDa precursor protein processed to 53 kDa within melanosomes.
- The protein exhibited properties consistent with a matrix constituent, requiring SDS for solubilization.
- Glycosylation occurred in the endoplasmic reticulum, with minimal subsequent Golgi processing.
- The protein was localized to the melanosome-rich large granule fraction.
- Expression was independent of tyrosinase-related protein family regulation.
Conclusions:
- An authentic component of the mammalian melanosomal matrix has been identified.
- The protein's characteristics support a bipartite pathway for melanosomal biogenesis.
- This matrix protein is distinct from the tyrosinase-related protein family in processing and regulation.
